TheProfitWatch

FDMT - 4D Molecular Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.22 -0.21 (-2.05%) --- 0.0 (0.0%) 0.0 (0.0%) -0.04 (-0.39%) -0.09 (-0.9%) -0.2 (-1.95%) -0.2 (-1.95%)

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.98
Diluted EPS:
-0.98
Basic P/E:
-10.2143
Diluted P/E:
-10.2143
RSI(14) 1m:
0.0
VWAP:
10.02
RVol:
0.6244

Events

Period Kind Movement Occurred At
1m Price decrease 1m 10.22 -0.16 (-1.54%) Oct 15 06:37

Related News